IFM Investors Pty Ltd increased its position in CME Group Inc. (NASDAQ:CME - Free Report) by 4.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 69,361 shares of the financial services provider's stock after purchasing an additional 2,798 shares during the quarter. IFM Investors Pty Ltd's holdings in CME Group were worth $19,117,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Perkins Coie Trust Co acquired a new stake in CME Group in the second quarter worth about $620,000. CWC Advisors LLC. grew its position in shares of CME Group by 3.0% during the 2nd quarter. CWC Advisors LLC. now owns 4,725 shares of the financial services provider's stock worth $1,302,000 after buying an additional 137 shares during the period. Exchange Traded Concepts LLC grew its position in shares of CME Group by 9.8% during the 2nd quarter. Exchange Traded Concepts LLC now owns 15,262 shares of the financial services provider's stock worth $4,207,000 after buying an additional 1,358 shares during the period. Andrew Hill Investment Advisors Inc. acquired a new position in shares of CME Group during the 2nd quarter worth about $1,507,000. Finally, Atticus Wealth Management LLC bought a new position in shares of CME Group during the 2nd quarter valued at about $133,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at CME Group
In related news, insider Sunil Cutinho sold 11,896 shares of the business's stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the business's stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider owned 9,508 shares of the company's stock, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,043 shares of company stock valued at $3,527,956. Corporate insiders own 0.30% of the company's stock.
CME Group Trading Down 0.7%
Shares of CME Group stock opened at $260.59 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52 week low of $212.38 and a 52 week high of $290.79. The stock has a 50 day moving average price of $272.25 and a two-hundred day moving average price of $270.52. The stock has a market capitalization of $93.91 billion, a PE ratio of 25.23, a price-to-earnings-growth ratio of 4.75 and a beta of 0.43.
CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the company earned $2.56 earnings per share. The company's revenue for the quarter was up 10.4% on a year-over-year basis. As a group, equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is currently 48.40%.
Analysts Set New Price Targets
Several equities research analysts have commented on the company. Citigroup boosted their target price on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. Wall Street Zen cut CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Oppenheimer boosted their target price on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. Barclays set a $298.00 price objective on CME Group and gave the stock an "equal weight" rating in a research note on Thursday, July 24th. Finally, UBS Group decreased their target price on CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a report on Monday, September 8th. Four equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, CME Group has a consensus rating of "Hold" and a consensus price target of $260.60.
View Our Latest Stock Analysis on CME Group
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.